Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates

BACKGROUND: Neonatal sepsis caused by multidrug-resistant gram-negative bacteria has been reported in different parts of the world. It is a major threat to neonatal care, carrying a high rate of morbidity and mortality. While Colistin is the treatment of choice, few studies have reported its use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-lawama, Manar, Aljbour, Haytham, Tanash, Asma, Badran, Eman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751699/
https://www.ncbi.nlm.nih.gov/pubmed/26868136
http://dx.doi.org/10.1186/s12941-016-0126-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751699/
https://www.ncbi.nlm.nih.gov/pubmed/26868136
http://dx.doi.org/10.1186/s12941-016-0126-4

Ejemplares similares